Find Funding

Innovative Molecular Analysis Technologies

The Innovative Molecular Analysis Technologies (IMAT) Program is aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research, treatment, diagnosis, and prevention. The IMAT Program utilizes different funding mechanisms to accomplish these goals, including the SBIR and STTR grant mechanisms. For more information about the IMAT Program, please visit: http://imat.cancer.gov/.

The IMAT Program includes the following three related thematic components:

  1. Innovative Technologies for the Molecular Analysis of Cancer, which emphasizes research projects that are centered on the inception and early stage development of new technologies for cancer research;
  2. Application of Emerging Technologies for Cancer Research, which is designed to support research projects evaluating technologies that are ready for initial clinical or laboratory application in cancer research; and
  3. Innovations in Cancer Sample Preparation, which is centered on the development of novel sample preparation technologies that are suitable for molecular analyses of cancer cells and their host environments.

Below is a listing of the most recent SBIR and STTR Programs IMAT funding opportunities. The three IMAT themes listed above possess one FOA for the SBIR Program and one for the STTR Program.

Past IMAT SBIR Funding Opportunities:


Past IMAT STTR Funding Opportunities: